What is the major toxicity concern with conventional amphotericin B?

Prepare for the Mycology Exam. Study with quizzes and multiple choice questions, each with hints and explanations. Master the subject!

Multiple Choice

What is the major toxicity concern with conventional amphotericin B?

Explanation:
Nephrotoxicity is the major toxicity associated with conventional amphotericin B. While the drug disrupts fungal cell membranes by binding ergosterol, it can also interact with cholesterol in human cell membranes, and the kidneys are especially exposed during IV administration. This leads to afferent arteriolar vasoconstriction and direct tubular injury, causing a drop in GFR and electrolyte wasting (notably potassium and magnesium). Because of this kidney toxicity, amphotericin B has historically limited use, though lipid formulations reduce, but do not completely eliminate, this risk. Other toxicities like ototoxicity, hepatotoxicity, or neutropenia can occur but are less characteristic of the conventional form.

Nephrotoxicity is the major toxicity associated with conventional amphotericin B. While the drug disrupts fungal cell membranes by binding ergosterol, it can also interact with cholesterol in human cell membranes, and the kidneys are especially exposed during IV administration. This leads to afferent arteriolar vasoconstriction and direct tubular injury, causing a drop in GFR and electrolyte wasting (notably potassium and magnesium). Because of this kidney toxicity, amphotericin B has historically limited use, though lipid formulations reduce, but do not completely eliminate, this risk. Other toxicities like ototoxicity, hepatotoxicity, or neutropenia can occur but are less characteristic of the conventional form.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy